Iridium 192 (Ir-192) is a radioactive isotope commonly used in medical applications, particularly in the field of brachytherapy. It emits gamma rays and has a half-life of approximately 74 days. The high energy of these gamma rays makes Ir-192 useful for treating various cancers, including those in gynecological oncology.